Literature DB >> 16086177

Evaluation of lacrimal fluid as an alternative for monitoring glucose in critically ill patients.

Jaclyn M Leblanc1, Curtis E Haas, Glorimar Vicente, Luis A Colon.   

Abstract

OBJECTIVE: This study evaluated the use of lacrimal fluid glucose concentrations as a minimally invasive, alternative sampling strategy for monitoring glucose concentrations in surgical/trauma ICU patients. DESIGN AND
SETTING: Prospective, paired sample study in an adult surgical/trauma ICU. PATIENTS: Patients receiving subcutaneous or intravenous insulin requiring routine capillary blood glucose measurements. Patients receiving ocular lubricants, artificial tears, or routinely administered ophthalmic medications and patients with facial injuries were excluded.
INTERVENTIONS: Lacrimal fluid was collected using glass capillary tube placed near the cul-de-sac of the eye. Capillary blood glucose was determined using a bedside glucose meter as per routine ICU care. MEASUREMENTS AND
RESULTS: Lacrimal fluid glucose concentration was analyzed using high-performance liquid chromatography with pulse amperometric detection. Forty-four paired samples from five patients were analyzed. Pearson correlation between lacrimal fluid (microM) and blood glucose (mM) concentrations and the proportional change from baseline revealed no significant associations. Due to the very poor association, enrollment was discontinued after five patients.
CONCLUSIONS: Lacrimal fluid and blood glucose concentrations were poorly correlated, suggesting that the former is not a reliable alternative to blood glucose monitoring in surgical/trauma ICU patients requiring insulin therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086177     DOI: 10.1007/s00134-005-2747-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Tear glucose estimation--an alternative to blood glucose estimation.

Authors:  B N Das; S Sengupta; B K Das; N R Goswami
Journal:  J Indian Med Assoc       Date:  1995-04

3.  Analysis of tear fluid by CE/LIF: a noninvasive approach for glucose monitoring.

Authors:  R Chen; Z Jin; L A Colón
Journal:  J Capillary Electrophor       Date:  1996 Sep-Oct

4.  Comparison of glucose levels in dermal interstitial fluid and finger capillary blood.

Authors:  P J Stout; N Peled; B J Erickson; M E Hilgers; J R Racchini; T B Hoegh
Journal:  Diabetes Technol Ther       Date:  2001       Impact factor: 6.118

5.  Tear glucose in uncontrolled and chemical diabetics.

Authors:  M S Gaur; G K Sharma; S G Kabra; P K Sharma; L K Nepalia
Journal:  Indian J Ophthalmol       Date:  1982-07       Impact factor: 1.848

6.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.

Authors:  A P Furnary; K J Zerr; G L Grunkemeier; A Starr
Journal:  Ann Thorac Surg       Date:  1999-02       Impact factor: 4.330

7.  Comparative quantitative analysis of sucrose and related compounds using ion exchange and reverse phase chromatographic methods.

Authors:  S Farine; C Villard; A Moulin; G Marchis Mouren; A Puigserver
Journal:  Int J Biol Macromol       Date:  1997-08       Impact factor: 6.953

8.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

Authors:  S K Garg; R O Potts; N R Ackerman; S J Fermi; J A Tamada; H P Chase
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

9.  Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes.

Authors:  S H Golden; C Peart-Vigilance; W H Kao; F L Brancati
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

10.  Tear glucose levels in normal people and in diabetic patients.

Authors:  D K Sen; G S Sarin
Journal:  Br J Ophthalmol       Date:  1980-09       Impact factor: 4.638

View more
  7 in total

1.  A disposable tear glucose biosensor-part 1: design and concept testing.

Authors:  Daniel K Bishop; Jeffrey T La Belle; Stephen R Vossler; Dharmendra R Patel; Curtiss B Cook
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  A contact lens with embedded sensor for monitoring tear glucose level.

Authors:  Huanfen Yao; Angela J Shum; Melissa Cowan; Ilkka Lähdesmäki; Babak A Parviz
Journal:  Biosens Bioelectron       Date:  2010-12-31       Impact factor: 10.618

3.  Flexible three-dimensional electrochemical glucose sensor with improved sensitivity realized in hybrid polymer microelectromechanical systems technique.

Authors:  Jasbir N Patel; Bonnie L Gray; Bozena Kaminska; Byron D Gates
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

Review 4.  Recent advances in fluorescent arylboronic acids for glucose sensing.

Authors:  Jon Stefan Hansen; Jørn Bolstad Christensen
Journal:  Biosensors (Basel)       Date:  2013-12-10

5.  Quantification of tear glucose levels and their correlation with blood glucose levels in dogs.

Authors:  Eunji Lee; Seonmi Kang; Jaeho Shim; Dajeong Jeong; Youngseok Jeong; Junyeong Ahn; Kangmoon Seo
Journal:  Vet Med Sci       Date:  2022-03-19

Review 6.  Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.

Authors:  Trisha Shang; Jennifer Y Zhang; Andreas Thomas; Mark A Arnold; Beatrice N Vetter; Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-06-13

7.  Development of a Ratiometric Fluorescent Glucose Sensor Using an Oxygen-Sensing Membrane Immobilized with Glucose Oxidase for the Detection of Glucose in Tears.

Authors:  Hong Dinh Duong; Ok-Jae Sohn; Jong Il Rhee
Journal:  Biosensors (Basel)       Date:  2020-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.